CellaVision AB (STU:C26)
€ 18.64 0.88 (4.95%) Market Cap: 454.18 Mil Enterprise Value: 445.31 Mil PE Ratio: 33.07 PB Ratio: 6.46 GF Score: 99/100

Q3 2020 CellaVision AB Earnings Call Transcript

Oct 23, 2020 / 09:00AM GMT
Release Date Price: €27.92 (-4.58%)
Operator

Ladies and gentlemen, welcome to the CellaVision AB Q3 report for 2020. Today, I'm pleased to present CEO, Zlatko Rihter. (Operator Instructions)

Zlatko, please begin.

Zlatko Rihter;publ;President;CEO
CellaVision AB

()-&

Thank you. Good morning, everybody. Zlatko here in Lunc together with Maria Morin, who is Head of Corporate Communications here; and also Magnus Blixt, CFO.

So I will take you through the presentation; and also, Magnus will chip in and help me today. So I'll start now. So please move to Slide #3.

And for those of you that haven't followed us throughout the years, I think it's important to give a little bit of a baseline. And then, of course, CellaVision, the vision and mission at the end of the day for us is to replace traditional microscopes in laboratories. And since we have a strong offering both when it comes to the outcomes side, that we can provide a good outcome in blood analysis, and we also improve efficiency by digitalizing the workflow in the lab and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot